Cargando…
Radium-223 Chloride: A New Treatment Option for Metastatic Castration-Resistant Prostate Carcinoma
In the last few years, the treatment of castration-resistant prostate carcinoma (CRPC) has changed completely. The approval of docetaxel and subsequent investigation in this field have led to development of new agents that have demonstrated an improvement in overall survival in the post-docetaxel se...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586060/ https://www.ncbi.nlm.nih.gov/pubmed/23190319 http://dx.doi.org/10.2165/11636250-000000000-00000 |